CCI
30
2
ECL
54
5
XOM
33
3
HCP
54
2
FITB
36
3
INTC
35
4
DHI
36
3
MPC
28
3
MAC
53
5
ABBV
40
5
AAPL
64
3
ACN
54
2
M
40
3
HRB
40
3
PNC
48
6
STZ
42
2
HSIC
42
2
MET
58
2
CMI
49
2
MTB
38
4
CCI
30
2
ECL
54
5
XOM
33
3
HCP
54
2
FITB
36
3
INTC
35
4
DHI
36
3
MPC
28
3
MAC
53
5
ABBV
40
5
AAPL
64
3
ACN
54
2
M
40
3
HRB
40
3
PNC
48
6
STZ
42
2
HSIC
42
2
MET
58
2
CMI
49
2
MTB
38
4
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
48

CHGCY
Chugai Pharmaceutical

Last Price:
$21.34
Seasonality Move:
5.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.9B
Cash Flow: $750M
Price / Cash Flow: 29.05
Annual Sales: $3.83
Price / Book: 5.57

Profitability

EPS (TTM): 0.78200
Net Income (TTM): $2.6B
Gross Margin: $5B
Return on Equity: 22.92%
Return on Assets: 19.59%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCY is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.89
Quick Ratio: 4.67

Price-to-Earnings

Trailing P/E Ratio: 30.27
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Sell
48
Chugai Pharmaceutical (CHGCY) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?